Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia

被引：5
|
作者：
Fiorini, A. [1 ]
Reddiconto, G. [1 ]
Farina, G. [1 ]
Marietti, S. [1 ]
Palladino, M. [1 ]
Chiusolo, P. [1 ]
Leone, G. [1 ]
Sica, S. [1 ]
机构：
[1] Catholic Univ Rome, Inst Hematol, Rome, Italy
来源：
LEUKEMIA | 2006年 / 20卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2404430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2198 / 2199
页数：2
相关论文
共 50 条
  • [31] Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis
    M Bornhäuser
    B Mohr
    U Oelschlaegel
    P Bornhäuser
    S Jacki
    G Ehninger
    C Thiede
    Leukemia, 2007, 21 : 1824 - 1826
  • [32] STUDY OF MYELOFIBROSIS USING JAK2 V617F EXPRESSING MACROPHAGES
    Silyutina, Anna
    Gin, Irina
    Prikhodko, Stanislava
    Butylin, Pavel
    Zaritskey, Andrey
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S65 - S65
  • [33] The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis
    Yip, SF
    So, CC
    Chan, AYY
    Liu, HSY
    Wan, TSK
    Chan, LC
    LEUKEMIA, 2006, 20 (06) : 1165 - 1165
  • [34] Sensitive Molecular Detection of JAK2 V617F Is a Predictive Marker of Relapse in Patients with Myelofibrosis after Allogeneic Stem Cell Transplantation
    Nedumannil, Rithin
    Karmi, Tal
    Blombery, Piers
    Hughes, Charlotte
    Szer, Jeff
    Ritchie, David S.
    Chee, Lynette C. Y.
    BLOOD, 2023, 142
  • [35] Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis
    Nedumannil, Rithin
    Karmi, Tal
    Blombery, Piers
    Szer, Jeff
    Ritchie, David S.
    Chee, Lynette C. Y.
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [36] Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis
    Silyutina, A. A.
    Gin, I. I.
    Prikhod'ko, S. S.
    Zhuk, S. V.
    Butylin, P. A.
    Zaritskii, A. Yu.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 164 (04) : 569 - 575
  • [37] The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis
    S-F Yip
    C-C So
    Ay-Y Chan
    Hs-Y Liu
    Ts-K Wan
    L-C Chan
    Leukemia, 2006, 20 : 1165 - 1165
  • [38] Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis
    A. A. Silyutina
    I. I. Gin
    S. S. Prikhod’ko
    S. V. Zhuk
    P. A. Butylin
    A. Yu. Zaritskii
    Bulletin of Experimental Biology and Medicine, 2018, 164 : 569 - 575
  • [39] Screening of JAK2 V617F mutation in multiple myeloma
    A Fiorini
    G Farina
    G Reddiconto
    M Palladino
    E Rossi
    T Za
    L Laurenti
    S Giammarco
    P Chiusolo
    G Leone
    S Sica
    Leukemia, 2006, 20 : 1912 - 1913
  • [40] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
12345